Radium-223 trials for Prostate cancer

All Radium-223 trials · All Prostate cancer trials

Phase breakdown

Recruiting trials studying Radium-223 for Prostate cancer

• AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
  NCT07611110 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 132 locations
• Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC)
  NCT04704505 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 2 locations
• SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment Optimization
  NCT06389097 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Radium-223 for Prostate cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.